Physician profile
Cecil Qiu
NPI 1881068765
$7,148.70
in general payments reported to CMS, 2019-2025
11 companies · $3,262 in 2025
The $3,262 reported for 2025 was more than what 90% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $935 · 2023: $146 · 2024: $2,806 · 2025: $3,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,695 · Travel and Lodging: $2,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,695.45 |
| Travel and Lodging | $2,517.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,975.33 | 2024-2025 | |
| Axogen | $1,385.37 | 2025 | |
| Allergan, INC. | $935.29 | 2021 | |
| Depuy Synthes Sales INC. | $606.94 | 2024-2025 | Trumatch, Matrixmandible, Matrixmidface |
| Stryker Corporation | $465.92 | 2023-2025 | Variax, Spy-Phi System, Na |
| Becton, Dickinson and Company | $364.80 | 2024-2025 | Phasix Mesh |
| Davol INC. | $157.11 | 2025 | Surgiphor |
| Ethicon US, LLC | $105.00 | 2025 | Vistaseal, Dermabond, Stratafix |
| Native Surgical, LLC | $102.44 | 2025 | |
| Baxter Healthcare | $29.45 | 2025 | Artiss |
| Olympus America INC. | $21.05 | 2025 | Orbeye Surgical Microscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecil Qiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.